Opexa (OPXA -18%) gets slammed today after posting a Q1 net loss of $0.58 per share,...

|About: Opexa Therapeutics, Inc. (OPXA)|By:, SA News Editor

Opexa (OPXA -18%) gets slammed today after posting a Q1 net loss of $0.58 per share, significantly wider than a year-ago, as operating expenses climbed. The company did manage to record $220K in revenue as part of its upfront payments from Merck Serono, versus no revenue during the year-ago quarter. There were no analyst estimates available for comparison.